Peak 2018 memorabilia
Release time:
2020-07-22
Peak 2018 Chronicle
1# July
1# November 12 , Tianjin Peak Natural Products Company obtained the BRC certification (Food Safety Global Standard 7 Edition), adding another "stepping stone" to further expand international markets such as Europe ".
January 19 , the group's board of directors passed a motion that peak pharmaceutical will invest in Shanghai north card pharmaceutical technology co., ltd. by acquiring shares and increasing capital to build a research and development and production base for bulk drugs.
July , the group company commended 2017 advanced collectives and outstanding individuals.
May 29 , the group company's special work meeting on safety and environmental protection decided to determine 2018 as the "year of safety education" to further strengthen safety education and training and effectively improve the level of safety in production.
60# to determine a series of commemorative activities. At the 2018 China Cement 50
4
4 September 11 , Jianfeng Group was awarded the "China Cement 50 Top" medal, ranking 35 . 4
13 , the Jianfeng Group Committee of the Communist Youth League held a congress and Chi Lifan was elected secretary of the new Youth League Committee. Group Company was rated as an advanced enterprise in talent development in Wucheng District. Yang Hao, R & D Department of Jianfeng Health Technology Company, and Lu Chaofang, Technical Quality Department of Cable Company, were selected as outstanding enterprise scientific and technological talents in Wucheng District of Jinhua City in 2017
Daye peak desulfurization technical transformation was completed and put into operation, thus becoming the first cement enterprise in Hubei Province to successfully implement desulfurization technical transformation.
4 July
, the company held a trail walk around the lake and seawall to commemorate the 91st anniversary of the peak start-up 60# "flying dreams, walking along yi. 5 May
Group Company Party Committee was awarded the honorary title of "2017 Advanced Primary Party Organization" by Jinhua Economic and Information Commission Party Committee.
"Peak" brand cement produced by Daye Peak won the title of "Hubei Famous Brand" for the third time in a row.
May , Jianfeng Group 2013
6# November September 5 , the "Civilized Travel, Start with Me" signature campaign jointly initiated by the Party Committee, Trade Union and Youth League Committee of the Group Company has been launched in all units of the Group.
12 , the peak enterprise university officially opened, adding a new way to the construction of peak talent team and education and training. 6
25 , Yunnan Jianfeng assisted Pu 'er municipal public security department to destroy 3000 kilograms of heroin and other drugs.
7 September 7 March 1
7
3 , the party Committee of the group company organized a centralized party class study. party Committee secretary Jiang xiaomeng analyzed the 19th national congress report and the situation at home and abroad, and put forward requirements for strengthening organizational construction and party members' own study. 7
17 to 20 , Zhejiang Building Materials Industry Association Calligraphy and Painting Photography Exhibition was held in Hangzhou, with nearly 20
7 May 28 Day, the trade union of the group company held a "Together in the same boat to create glory, let the mood fly and set sail again" to commemorate the 60th 169 anniversary of the peak start-up staff fun games.
August June August
, the board of directors deliberated and approved three proposals: Jianfeng Pharmaceutical's capital increase to Shanghai Beika, Shanghai Beika's acquisition of Anhui Zhongwang Pharmaceutical Company and Jianfeng Pharmaceutical Jinxi Production Base's annual production of
.4 billion tablets of solid preparations. Jianfeng Pharmaceutical's territory expanded again.
2019 - 2023 Development Strategy", and the three-year business plans of various professional companies and directly affiliated enterprises also began to be compiled simultaneously. August
29 , the Youth League Committee of the Group Company held a speech contest on the theme of "feeling, growth, blessing and development" to commemorate the 60th anniversary of the 198 of Peak Venture. 9
9 13 , the opening ceremony of Anhui Jianfeng Beika Pharmaceutical Small Molecule Targeted Drug Research Institute was held in Anhui Dongzhe Economic Development Zone.
10 March
10 July 10 to 17
was held in Jianfeng Building.
10 July 20 , the sixth group of the second contact research group of the all-China Federation of Industry and Commerce visited Jianfeng Group for investigation and research, and organized a research symposium. November 23 March
2 , Zhejiang province non-public economic personage new era outstanding builders of socialism with Chinese characteristics commendation conference was held in the provincial great hall of the people, group chairman Jiang Xiaomeng and other 240 55 entrepreneurs were commended.
2018 China Building Materials Enterprises 100
11 February 3 evening, "unite together, create another brilliant" to commemorate the 60th anniversary of peak entrepreneurship 256 held in Jinhua.
November 260 22 , Yunnan Jianfeng Cement Company's P.O42.5 Ordinary Portland Cement passed the low-carbon product certification of China Quality Certification Center.
12 August 12 February
at the "2018 Annual Pharmaceutical Industry New Profits List" award ceremony, Jianfeng Pharmaceutical won the honor of "2018 Annual Most Brand Value Pharmaceutical Enterprise.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31